Effect of Probiotics on Infant's Fecal Microbiota Composition
Safety, Tolerability and Effect on Fecal Microbiota Composition of Two Probiotic Strains in Infants
AB Biotics, SA
120 participants
Jun 1, 2022
INTERVENTIONAL
Conditions
Summary
Randomized clinical trial to evaluate the effect of two probiotic strains which belong to Bifidobacterium Longum and Pediococcus pentosaceus species on fecal microbiota composition in healthy infants. Secondary outcomes comprise evaluation of anthropometric growth, digestive tolerance, sleeping habits, incidence of functional gastrointestinal disorders, incidence of gastrointestinal and respiratory infections, allergic reactions and safety and tolerability of the product.
Eligibility
Inclusion Criteria6
- Healthy infants
- Age between 1 and 90 days
- Gestational age between 37 and 42 weeks
- Appropiate birth weight for gestational age (between P10 and P90)
- APGAR test score for birth normal at 1' and 5' of 7-10
- Whose parents accept the follow-up of the study procedures and sign the informed consent
Exclusion Criteria9
- Infants participating in other clinical study
- Fed with infant formula containing probiotics or other aliments or food supplement based in probiotics 4 weeks prior the start of the study
- Infants who have taken antibiotics 4 weeks prior the start study
- Infants with cow's milk protein allergy, lactose intolerance or other digestive diseases
- Mother's pathological background and during gestation: neurologic disorders, matabolopaties, diabetes mellitus type 1, chronic disease (hypothyroidism), maternal malnutrition
- Acute congenital or acquired diseases which can interfere with the growth and the normal feeding of the infant
- TORCH complex infections
- Every other diseases related with the immune system
- Parents who can not accomplish the follow-up of the study (medical criterium)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Probiotic single strain formulation containing Bifidobacterium longum CECT7894 for 3 months 5 drops/day
Probiotic single strain formulation containing Pediococcus pentosaceus CECT8330 for 3 months 5 drops/day
5 drops/day for 3 months of sunflower oil
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05524649